Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02992912 |
Title | Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1) |
Recruitment | Unknown status |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Gustave Roussy, Cancer Campus, Grand Paris |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA |